<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><description>Sometimes tweeting about T cells, Vaccines, Viruses, TCRs,  Immunogen Design, AI, Viral Seq Evolution...&#xA;PI: Leo Swadling&#xA;@IIT_UCL 🍐&#xA;www.researchgate.net/profile/Leo-Swadling&#xA;profiles.ucl.ac.uk/61477-leo-swadling</description><link>https://bsky.app/profile/tcellvaccineucl.bsky.social</link><title>@tcellvaccineucl.bsky.social - T cell Vaccines Lab (Swadling UCL) 🧬👩🏽‍🔬</title><item><link>https://bsky.app/profile/tcellvaccineucl.bsky.social/post/3m6epnkzoms2w</link><description>One week until the Swadling Lab heads to #BSI25!&#xA;We have 4 members presenting this year — 3 posters + 1 talk — covering T cell responses, SARS-CoV-2, and vaccine design.&#xA;Come find us and say hello!&#xA;#vaccines #immunology #Tcells #virus</description><pubDate>24 Nov 2025 11:24 +0000</pubDate><guid isPermaLink="false">at://did:plc:j4jffdrtzx2odd45vstucymp/app.bsky.feed.post/3m6epnkzoms2w</guid></item><item><link>https://bsky.app/profile/tcellvaccineucl.bsky.social/post/3m5tjheixpk2t</link><description>🚨Preprint🚨: To better utilise the potential for cross-protective T cells in HPV vaccines we would like to take a rational approach to designing T-cell inducing HPV vaccines (prophylactic and therapeutic) ⚔️ &#xA;&#xA;https://www.medrxiv.org/content/10.1101/2025.11.03.25339381v1</description><pubDate>17 Nov 2025 15:18 +0000</pubDate><guid isPermaLink="false">at://did:plc:j4jffdrtzx2odd45vstucymp/app.bsky.feed.post/3m5tjheixpk2t</guid></item><item><link>https://bsky.app/profile/tcellvaccineucl.bsky.social/post/3m3wkmfwafs2g</link><description>Ever heard of this #vaccination side effect? SARS-CoV-2 mRNA vaccination significantly increased anti tumour responses and survival in patients with metastatic melanoma and NSCLC undergoing treatment with ICIs.&#xA;&#xA;https://www.nature.com/articles/s41586-025-09655-y&#xA;&#xA;#vaccineswork #tcells #immunology</description><pubDate>24 Oct 2025 09:26 +0000</pubDate><guid isPermaLink="false">at://did:plc:j4jffdrtzx2odd45vstucymp/app.bsky.feed.post/3m3wkmfwafs2g</guid></item><item><link>https://bsky.app/profile/tcellvaccineucl.bsky.social/post/3lt2ly2ae2k2m</link><description>An HA/NP/IL-1B adenovirus led to a different profile of lung-resident Trms than natural H1N1 infection with the adjuvanted vaccine leading to longer lived lung-resident Trms than infection.&#xA;https://pmc.ncbi.nlm.nih.gov/articles/PMC12003732/ &#xA;#immunology #vaccine #Tcell #memory</description><pubDate>03 Jul 2025 11:14 +0000</pubDate><guid isPermaLink="false">at://did:plc:j4jffdrtzx2odd45vstucymp/app.bsky.feed.post/3lt2ly2ae2k2m</guid></item><item><link>https://bsky.app/profile/tcellvaccineucl.bsky.social/post/3lrxtn637qc2z</link><description>5 charts that show #vaccineswork&#xA;https://www.nature.com/articles/d41586-025-00862-1</description><pubDate>19 Jun 2025 15:28 +0000</pubDate><guid isPermaLink="false">at://did:plc:j4jffdrtzx2odd45vstucymp/app.bsky.feed.post/3lrxtn637qc2z</guid></item><item><link>https://bsky.app/profile/tcellvaccineucl.bsky.social/post/3lruoqfw7vc23</link><description>Another nice study illustrating that targeting responses to the nasal mucosa could be superior to systemic administration. The CAF09b adjuvant plus recombinant protein in an i.n. vaccine induced better nasal IgA and CD8 responses than i.m. mRNA.</description><pubDate>18 Jun 2025 09:22 +0000</pubDate><guid isPermaLink="false">at://did:plc:j4jffdrtzx2odd45vstucymp/app.bsky.feed.post/3lruoqfw7vc23</guid></item><item><link>https://bsky.app/profile/tcellvaccineucl.bsky.social/post/3lrs57ybc4c2m</link><description>Cool to see this upcoming phase 2 clinical trial for aerosolised vaccine formulations, with planned measurements of lung T cell responses&#xA;https://publications.ersnet.org/content/erjor/11/3/00758-2024&#xA;#clinicaltrial #tcell #vaccineswork #immunology #vaccine</description><pubDate>17 Jun 2025 09:04 +0000</pubDate><guid isPermaLink="false">at://did:plc:j4jffdrtzx2odd45vstucymp/app.bsky.feed.post/3lrs57ybc4c2m</guid></item><item><link>https://bsky.app/profile/tcellvaccineucl.bsky.social/post/3lrprzislgs2z</link><description>New interesting data on the role of T cells in Ad26-COV2.S-mediated immunity to SARS-CoV-2! Back in 2021, a phase 3 study showed that single dose was able to confer protection from symptomatic COVID-19 and reduced severity of any breakthrough infections.</description><pubDate>16 Jun 2025 10:38 +0000</pubDate><guid isPermaLink="false">at://did:plc:j4jffdrtzx2odd45vstucymp/app.bsky.feed.post/3lrprzislgs2z</guid></item><item><link>https://bsky.app/profile/tcellvaccineucl.bsky.social/post/3lqq2zcb3os2t</link><description>Jamie and Leo will be at #ExRdFest Saturday representing IMMPROVE&#xA;&#xA;🧪🧬at the &#34;would you get sick for science&#34; stand 🧪🧬&#xA;&#xA;talking about human challenge, vaccines and immunology!  &#xA;&#xA;www.greatexhibitionroadfestival.co.uk&#xA;&#xA;https://www.imperial.ac.uk/institute-of-infection/about-us/pandemic-preparedness/human-challenge-studies/&#xA;&#xA;immprove.ac.uk&#xA;https://www.greatexhibitionroadfestival.co.uk/</description><pubDate>03 Jun 2025 19:54 +0000</pubDate><guid isPermaLink="false">at://did:plc:j4jffdrtzx2odd45vstucymp/app.bsky.feed.post/3lqq2zcb3os2t</guid></item><item><link>https://bsky.app/profile/tcellvaccineucl.bsky.social/post/3lpccajpqk22w</link><description>We also have two new students, Priya and Nistha. Priya will be using wet and dry lab work to identify conserved T cell targets in HCoVs for vaccine design, and Nishtha will be studying how varied inhaled vaccines stimulate innate immunity and effects on T cell responses (3/3)</description><pubDate>16 May 2025 15:01 +0000</pubDate><guid isPermaLink="false">at://did:plc:j4jffdrtzx2odd45vstucymp/app.bsky.feed.post/3lpccajpqk22w</guid></item><item><link>https://bsky.app/profile/tcellvaccineucl.bsky.social/post/3lpcc7qwplk2w</link><description>We&#39;re proud to host Dr Xiuyuan Lu from Osaka University as part of the IIT &amp; IFReC exchange programme. She comes with great skills in analysing T cell vaccination responses. We&#39;re looking forward to her upcoming talk and of course future collaboration! (2/3)&#xA;&#xA;#UCL #IFReC #vaccine</description><pubDate>16 May 2025 15:00 +0000</pubDate><guid isPermaLink="false">at://did:plc:j4jffdrtzx2odd45vstucymp/app.bsky.feed.post/3lpcc7qwplk2w</guid></item><item><link>https://bsky.app/profile/tcellvaccineucl.bsky.social/post/3lpcc4zw64k2w</link><description>Standing room only our recent lab meeting! The group is growing fast, and lots of great science will surely come soon! (1/3)</description><pubDate>16 May 2025 14:59 +0000</pubDate><guid isPermaLink="false">at://did:plc:j4jffdrtzx2odd45vstucymp/app.bsky.feed.post/3lpcc4zw64k2w</guid></item><item><link>https://bsky.app/profile/tcellvaccineucl.bsky.social/post/3lmhyh4tcms2d</link><description>(2/2)&#xA;&#xA;My final thought for the day, is that from mechanistic insights or enhancing and developing medicines, it’s exciting to see quantitative research taking increasing space in immunology. Let’s keep the momentum going!&#xA;&#xA;Postdoc Peter, signing off.&#xA;&#xA;#qimmunoday</description><pubDate>10 Apr 2025 17:06 +0000</pubDate><guid isPermaLink="false">at://did:plc:j4jffdrtzx2odd45vstucymp/app.bsky.feed.post/3lmhyh4tcms2d</guid></item><item><link>https://bsky.app/profile/tcellvaccineucl.bsky.social/post/3lmhyge5m4k2d</link><description>(1/2)&#xA;&#xA;Another successful #qimmuno day has drawn to a close, but discussions continue in the pub around the corner! Congrats to the organising committee @qimmuno.bsky.social for an excellent day and to all the speakers for engaging talks.</description><pubDate>10 Apr 2025 17:05 +0000</pubDate><guid isPermaLink="false">at://did:plc:j4jffdrtzx2odd45vstucymp/app.bsky.feed.post/3lmhyge5m4k2d</guid></item><item><link>https://bsky.app/profile/tcellvaccineucl.bsky.social/post/3lmhqobh3p22x</link><description>(3/3)&#xA;&#xA;Xiaowen Chen was the final presenter, and presented novel research into how we can infer resource competition from dynamic abundance data. A very interesting topic, which has some cool potential overlaps with T and B cell competition for antigens and/or cytokines.&#xA;&#xA;Now for posters!</description><pubDate>10 Apr 2025 14:46 +0000</pubDate><guid isPermaLink="false">at://did:plc:j4jffdrtzx2odd45vstucymp/app.bsky.feed.post/3lmhqobh3p22x</guid></item><item><link>https://bsky.app/profile/tcellvaccineucl.bsky.social/post/3lmhqnffyo22x</link><description>(2/3)&#xA;&#xA;Pebs Edwards presented some interesting data on the TCR repertoire in patients with lynch syndrome. A personal highlight for me was the 2 year persistence of neo-antigen clonotypes with apparent subsequent reactivation in at least one patient.</description><pubDate>10 Apr 2025 14:46 +0000</pubDate><guid isPermaLink="false">at://did:plc:j4jffdrtzx2odd45vstucymp/app.bsky.feed.post/3lmhqnffyo22x</guid></item><item><link>https://bsky.app/profile/tcellvaccineucl.bsky.social/post/3lmhqlcgqok2x</link><description>(1/2)&#xA;&#xA;Final set of talks now. Aubin Ramon started by describing his work to develop NanoMelt for nanobody thermostability assessment. The model uses ensemble learning on just 640 sequences, but accurately predicted Tm in a selection of nanobodies with at least 30% distance from the training set.</description><pubDate>10 Apr 2025 14:45 +0000</pubDate><guid isPermaLink="false">at://did:plc:j4jffdrtzx2odd45vstucymp/app.bsky.feed.post/3lmhqlcgqok2x</guid></item><item><link>https://bsky.app/profile/tcellvaccineucl.bsky.social/post/3lmhmpsfsqs2x</link><description>(2/2)&#xA;&#xA;Alastar Phelan then spoke about his mathematical modelling approach to enhance signal detection in dual pulse nucleoside labelling experiments for improving cell cycle analysis.&#xA;&#xA;Both speakers showcased their work really well, armed with only a pen and whiteboard!&#xA;&#xA;#qimmunoday</description><pubDate>10 Apr 2025 13:36 +0000</pubDate><guid isPermaLink="false">at://did:plc:j4jffdrtzx2odd45vstucymp/app.bsky.feed.post/3lmhmpsfsqs2x</guid></item><item><link>https://bsky.app/profile/tcellvaccineucl.bsky.social/post/3lmhmolrvwc2x</link><description>(1/2)&#xA;&#xA;A nice, unique feature of these days is the whiteboard talks.&#xA;&#xA;Michael Schneider went first and gave a nice explanation of how he is augmenting structure enhanced language models by improving MLM with intelligent token masking and space filling curves.</description><pubDate>10 Apr 2025 13:35 +0000</pubDate><guid isPermaLink="false">at://did:plc:j4jffdrtzx2odd45vstucymp/app.bsky.feed.post/3lmhmolrvwc2x</guid></item><item><link>https://bsky.app/profile/tcellvaccineucl.bsky.social/post/3lmhgi3xdj22v</link><description>(3/3)&#xA;&#xA;Alexis Farman discussed his mathematical models for CAR T cell migration conditions in a microfluidics device, focussing on chemoattractant availability. An interesting tidbit to finish on, where optimisation of receptor affinity was discussed, overlapping nicely with Pietro’s talk.</description><pubDate>10 Apr 2025 11:44 +0000</pubDate><guid isPermaLink="false">at://did:plc:j4jffdrtzx2odd45vstucymp/app.bsky.feed.post/3lmhgi3xdj22v</guid></item><item><link>https://bsky.app/profile/tcellvaccineucl.bsky.social/post/3lmhgfh57x22v</link><description>(2/3)&#xA;&#xA;Constantin Ahlmann-Eltze showcased impressive work on assembling an atlas of T cells in precancerous samples. They developed the R packages treelabel and Shinytreelabel, which showed GITR+ Tregs are enriched in several precancerous samples, suggesting avenues for future treatments</description><pubDate>10 Apr 2025 11:43 +0000</pubDate><guid isPermaLink="false">at://did:plc:j4jffdrtzx2odd45vstucymp/app.bsky.feed.post/3lmhgfh57x22v</guid></item><item><link>https://bsky.app/profile/tcellvaccineucl.bsky.social/post/3lmhgdxp5t22v</link><description>(1/3)&#xA;&#xA;Session 2 followed on with engaging talks.&#xA;&#xA;Pietro Sormanni discussed his group’s work on utilising ML to develop and enhance AIRR based therapeutics. Great to see this ML work backed up with experimental analysis. Work with industrial partners promises to produce real benefits for patients.</description><pubDate>10 Apr 2025 11:42 +0000</pubDate><guid isPermaLink="false">at://did:plc:j4jffdrtzx2odd45vstucymp/app.bsky.feed.post/3lmhgdxp5t22v</guid></item></channel></rss>